Arca
Skip to content

Braf mutation-positive tumors

Drug research and approvals for braf mutation-positive tumors: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 10 studies of braf mutation-positive tumors are recruiting on ClinicalTrials.gov, and Health Canada has authorized 5 drug trials for it since 2013.

  • Recruiting worldwide: 10
  • Trials authorized in Canada: 5
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 10 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Jul 3, 2019An open label, multi-center roll-over study to assess long-term effect in pediatric patients treated with tafinlar (dabrafenib) and/or mekinist (trametinib)DABRAFENIB (DRB436)/ TRAMETINIB (TMT212)Novartis Pharmaceuticals CorporationOngoing
Mar 18, 2016Phase II open-label global study to evaluate the effect of dabrafenib treatment in children and adolescent patients with braf v600 mutation positive relapsed…TAFINLAR (DABRAFENIB, DRB436)/ TRAMETINIBNovartis Pharmaceuticals CorporationClosed
Jun 23, 2014An open-label, dose-escalation, phase I/ii study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of the mek inhibitor…TRAMETINIB (GSK1120212) / DABRAFENIB (GSK2118436)Novartis Pharmaceuticals CorporationClosed
Nov 15, 2013A phase II, open-label, study in subjects with braf v600e-mutated rare cancers with several histologies to investigate the clinical efficacy and safety of the…DABRAFENIB (GSK2118436)/ TRAMETINIB (GSK1120212)Novartis Pharmaceuticals CorporationClosed
Oct 23, 2013A phase 1 and pharmacokinetic study of dabrafenib (gsk2118436b) in patients with brafv600x mutations and renal or hepatic dysfunction.DABRAFENIBPRINCESS MARGARET HOSPITAL PHASE I CONSORTIUMOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.